Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has risen 7.26% since its last report, with 1.23 million shares sold short, which is 1.33% of all regular shares available for trading. It would take traders 2.54 days to cover their short positions on average. The company's short interest is less than its peer group average of 4.19%.
July 03, 2023 | 1:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals's short percent of float has risen, indicating increased bearish sentiment. However, its short interest is less than its peer group average.
The rise in short percent of float indicates that traders are expecting the price of Regeneron Pharmaceuticals to fall. However, the fact that its short interest is less than its peer group average suggests that the bearish sentiment is not as strong as it could be.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100